
BrainsWay Ltd. (BWAY) Stock Ticker
BWAY right now
Market factors today
Unlock the full BWAY picture
About BrainsWay Ltd.
BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets. Its primary offering is the Deep Transcranial Magnetic Stimulation (dTMS) platform technology, which provides treatment for various ailments including major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's clientele primarily comprises medical professionals, hospitals, and medical centers specializing in psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
BWAY stock facts
| Ticker symbol | BWAY |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Medical - Specialties |
| Market cap | $522.1M |
| CEO | Hadar Levy |
| Employees | 129 |
| Headquarters | Jerusalem, JM, IL |
| IPO date | 2019-04-17 |
| Website | www.brainsway.com |
What you can see for BWAY on Tickr
Live BWAY price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the BWAY report.
Rankings
FAQ
What is the ticker symbol for BrainsWay Ltd.?
The ticker symbol for BrainsWay Ltd. is BWAY, listed on the NASDAQ Global Market.
What is BWAY?
BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets. Its primary offering is the Deep Transcranial Magnetic Stimulation (dTMS) platform technology, which provides…